GlobeNewsWire
30 Oct 2025, 20:05 UTC · 52w ago
iRhythm Technologies Announces Third Quarter 2025 Financial Results
Impact · against what's priced in
iRhythm Technologies is hitting a critical fundamental inflection point by achieving annual free cash flow positivity for the first time while maintaining 30.7% year-over-year revenue growth. The narrowing net loss and expansion into sleep diagnostics provide a clear path toward GAAP profitability and long-term scalability.
- IRTC+0.70
No priced-in read yet
- In context
The transition to annual free cash flow positivity in 2025, combined with 30.7% year-over-year revenue growth to $192.9 million, marks a significant shift in the company's financial profile from a loss-making growth entity to a self-sustaining operation.
Read from the article alone
